Leiner Plans Suit Against Dr. Reddy’s, Expects Delay Restarting OTC Business
This article was originally published in The Tan Sheet
Executive Summary
Leiner Health Products' restart of its U.S. OTC operations could be delayed due to the loss of an exclusive ingredient supply contract with Dr. Reddy's Laboratories, the Carson, Calif.-based firm says
You may also be interested in...
Leiner Files For Chapter 11 Protection, Explores Selling Business
Leiner Health Products' shutdown of its U.S. OTC operations a year ago forced the firm to seek Chapter 11 bankruptcy protection and explore selling its U.S. business
Leiner Files For Chapter 11 Protection, Explores Selling Business
Leiner Health Products' shutdown of its U.S. OTC operations a year ago forced the firm to seek Chapter 11 bankruptcy protection and explore selling its U.S. business
Plethico’s Natrol Acquisition Reflects Growing Indian Supplement Investment
Plethico Pharmaceuticals' $80.8 million acquisition of Natrol could be a bellwether of Indian firms' interest in growing their presence in the U.S. supplement market